A high eosinophil proportion increases the risk of skin-related adverse events induced by apalutamide in patients with prostate cancer. - Tasaki Y; Naiki T; Mimura Y; Sugiyama Y; Tomita M; Morikawa T; Nagai T; Unno R; Etani T; Hamamoto S; Umemoto Y; Yasui T; et al. (Frontiers in immunology, 2025)